NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis.

JG, O'Leary; KR, Reddy; G, Garcia-Tsao; SW, Biggins; F, Wong; MB, Fallon; RM, Subramanian; PS, Kamath; P, Thuluvath; HE, Vargas; B, Maliakkal; P, Tandon; J, Lai; LR, Thacker; JS, Bajaj

doi:10.1002/hep.29773

Public

NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis.

Shared by NobleBlocks on Apr 19, 2018 • 12:00 AM UTC

Authors:

O'Leary JG

Reddy KR

Garcia-Tsao G

Abstract

The North American Consortium for the Study of End-Stage Liver Disease's definition of acute-on-chronic liver failure (NACSELD-ACLF) as two or more extrahepatic organ failures has been proposed as a simple bedside tool to assess the risk of mortality in hospitalized patients with cirrhosis. We valid...

Discussions